Advanced Topics in Lyme Disease (Burrascano)

Dr Joeseph J. Burrascano, Jr’s paper on Lyme diagnosis & treatment.

Statistical Review of the Key Lyme Studies Reveals the ‘Wild Conjecture’ Behind the IDSA Guidelines

In a comment to the article, “Study reports flaws in design, analysis, and interpretation of Lyme disease,” Phyllis Mervine elucidates what happened from the depth of her involvement at the NIH at the time of the Klempner clinical trial … NIH Should Admit They Were Wrong Phyllis Mervine says: September 5, 2012 at 7:53 PM […]


US Congressional Hearing on Lyme Disease

Video streaming by Ustream This meeting took place in the US House of Representatives on July 17, 2012. [Please scroll ahead, hearing begins at minute 28:00 of the video.] Subcommittee on Africa, Global Health, and Human Rights Chaired by Christopher H. Smith (R-NJ) Witnesses from the IDSA, CDC and NIH were invited to the hearing […]

“Single-Dose Doxy” for prevention is not supported by science or common sense

Here’s the link to Dr Elizabeth Maloney’s paper, “Challenge to the Recommendation on the Prophylaxis of Lyme Disease” (PDF). The “Prophylaxis Recommendation” of the IDSA Guidelines — Recommendation #2 — is poorly supported by its only supporting literature. Moreover, the “Single-Dose Doxy” practise is difficult to implement in a clinical setting; and furthermore, it is, in […]

The ILADS Guidelines

PLEASE REFER TO THE NEW ILADS GUIDELINES (published August 2014) “The ILADS Guidelines” is what we call the most important document in the clinical diagnosis, treatment and healing of CHRONIC Lyme Disease. The document contains the authoritative guidelines for treatment. Only these guidelines acknowledge the persistence and chronic nature of tick-borne infections. It’s a document […]